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Escherichia coli DNA photolyase was overproduced 
and purified from each of two mutant E. coli strains 
lacking dihydrofolate reductase. The extent of over- 
production in the mutants was comparable to that seen 
in the wild type strain. Examination of the isolated 
photolyase from these strains revealed that the folate 
cofactor, 5,10-methenyltetrahydrofolate, was present 
in these proteins at a level of 60-80% compared to that 
purified from the wild type strain. Further examina- 
tion of the dihydrofolate reductase-deficient strains 
revealed the presence of other tetrahydrofolate deriv- 
atives. These findings demonstrate that dihydrofolate 
reductase is not essential for the production of tetra- 
hydrofolates in E. coli. 
Folate cofactors are of critical importance in intermediary 
metabolism. These essential cofactors are synthesized de nouo 
in bacteria and plants but are derived from dietary sources in 
mammals, including man. In Escherichia coli, folates are 
known to be derived from GTP as shown in Scheme 1. The 
reduction of 7,8-H*folate’ to H4folate is an obligatory step in 
the synthesis of the single carbon carrier forms of the molecule 
(Scheme 2). This conversion is catalyzed by dihydrofolate 
reductase, and the reaction is considered to be the sole source 
of cellular H4folates in E. coli. 
Dihydrofolate reductase has long been the focus of mecha- 
nistic studies, particularly the targeting of drugs such as 
methotrexate and trimethoprim which are thought to cause 
cell death by inhibiting the formation of Hlfolate. To facilitate 
structure-function studies on the enzyme by the technique of 
site-directed mutagenesis, construction of a dihydrofolate re- 
ductase-deficient (fol-) strain is desirable. Because of the 
cellular importance of this enzyme for generating a multitude 
of essential compounds for the folate-dependent reactions in 
the cell, the survival of such a mutant would appear to be 
difficult. Nevertheless, the construction of two dihydrofolate 
reductase mutants by deletion of the fol gene was reported 
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recently by two separate laboratories (2, 4). This fol deletion 
was stable only in the presence of an accompanying mutation 
in thymidylate synthetase. 
In order to understand the details of folate metabolism in 
these mutants, we have analyzed the folate pool in each 
mutant, LH18 and PA414. Our findings are that both strains 
contain Hlfolates. Thus, it appears that another enzyme or 
pathway exists in E. coli for the production of Hlfolates in 
addition to the reaction or pathway involving dihydrofolate 
reductase. 
MATERIALS AND METHODS 
Chemicals and Reagents-Sodium cyanoborohydride was from Ald- 
rich. Tetrabutylammonium hydroxide, Hlfolate, 5-CHO-H4folate, 
H*folate, NADH, activated charcoal, tetracycline, kanamycin, meth- 
otrexate, thymine, adenine, glycine, L-methionine, and ammonium 
dihydrogen phosphate were from Sigma. NADPH was purchased from 
Pharmacia LKB Biotechnology Inc. Folic acid was from Nutritional 
Biochemicals, and HPLC grade methanol was obtained from Fisher. 
DL-Pantothenic acid was from Brothers Chemical Co. IsOprOpyl-P-D- 
thiogalactoside was purchased from Boehringer Mannheim Biochem- 
icals. All other amino acids used were from Sigma. 
Bacterial Strains-The E. coli strains used in this study are listed 
in Table I. LH18 and PA414 were maintained on LB plates containing 
25 Kg/ml kanamycin and 200 fig/ml thymine. AB1157 and NM522 
were maintained on LB plates. For growth of cells for folate analysis 
or enzymatic assays, Fernbach flasks containing 1 liter of LB 
(NM522, AB1157) plus 200 pg/ml thymine and 25 pg/ml kanamycin 
(LH18, PA414) were inoculated with single colonies and grown for 
18 h on a shaker table at 37 “C. Alternatively, Fernbach flasks were 
inoculated with 0.5-5 ml log-phase cultures and grown for 12 h with 
shaking at 37 “C. 
For the determination of growth requirements, LH18 and PA414 
were grown on minimal agar plates (7) containing kanamycin (50 fig/ 
ml), kanamycin and thymine (200 pg/ml), or kanamycin, thymine, 
adenine (20 rg/ml), L-methionine (50 wg/ml), glycine (50 pg/ml), and 
pantothenic acid (1 fig/ml). Minimal plates contained additionally 
thiamin (1 fig/ml) and 50 pg/ml L-proline, L-arginine, L-histidine, L- 
leucine, and L-threonine. 
MS09 was maintained on LB plates containing 20 pg/ml tetracy- 
cline. SHAlO and UNC414 were maintained on LB plates with 200 
*g/ml thymine and 20 pg/ml tetracycline. Growth of these strains for 
photolyase induction and purification was in LB + 20 rg/ml tetra- 
cycline (MS09) with an additional 200 rg/ml thymine (SHAlO, 
UNC414). Twenty-five-ml cultures were inoculated with single colo- 
nies and grown overnight, and 5-ml aliquots of the culture were added 
to 2-liter flasks containing 500 ml of the appropriate media. The 
flasks were shaken at 37 “C until the A was approximately 0.6, induced 
with 1 mM isopropyl-P-D-thiogalactoside, and shaken 12-16 h before 
harvesting. 
For the construction of UNC414, PA414 was mated with CSR603 
(5) and transformed with pMS1310. SHAlO was constructed by 
transforming LH18 with pMS1310. 
Plasma y-Glutamyl Hydrolase-Rat plasma y-glutamyl hydrolase 
was prepared by a method based on that of Wilson and Horne (8). 
About 20 Zivic-Muller rats were anesthetized and decapitated. Blood 
was collected into a beaker containing 1 ml of sodium heparin (Upjohn 
Chemical Co., 1000 units/ml). The blood was centrifuged at 15,000 
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rpm for 20 min at 4 “C in the SS34 rotor of a Sorvall refrigerated 
centrifuge. The serum supernatant was collected and dialyzed 16-20 
h against 1 liter of 50 mM potassium phosphate, pH 7.4, containing 
2 g of activated charcoal. The serum was concentrated 2-fold to 3- 
fold by ultrafiltration using a PM10 membrane (Amicon) and frozen 
at -20 ‘C until needed. 
Protein Purification-The procedure for purification of E. coli 
DNA photolyase was modified from that described previously (9). 
Purification was completed after elution from Blue Sepharose and 
passage over a Sephadex G-25 column (PD-10, Pharmacia LKB 
Biotechnology Inc., 9.1-ml bed volume) in 50 mM Tris-HCl, pH 7.4, 
50 mM NaCl, 1 mM EDTA. Photolyase concentration was determined 
after treatment with potassium ferricyanide to convert all residual 
FADHZ to the stable blue flavin radical* followed by measurement of 
the absorbance at 580 nm and using an extinction coefficient of 5000 
M-’ cm-’ as previously described (9). 
Protein and Enzyme Assays-Protein assays were performed with 
BCA Protein Assay Reagent (Pierce) with bovine serum albumin as 
a standard. Assay of E. coli dihydrofolate reductase was based on that 
* S. Hamm-Alvarez, unpublished results. 
of Stone and Morrison (10, 11) and was performed as follows: 12 to 
50 ~1 of crude E. coli extract was added to 2.5 ml of 50 mM Tris-HCl, 
pH 7.4, containing 1 mM EDTA, 1 mM dithiothreitol, and 100 GM 
NADPH. One-ml aliquots of the mixture were added to each of two 
cuvettes. Dihydrofolate was added to 20 PM in the sample cuvette, 
and an equal volume of buffer was added to the reference cuvette. 
The change in absorbance at 340 nm was followed using a Shimadzu 
UV-260 spectrophotometer. Methotrexate concentration ranged from 
0.25 ELM to 1 PM when present. 
Synthesis of FoEares-CH+-H4folate was synthesized from 5-CHO- 
H,folate as described previously (12). CH3-H4folate was synthesized 
from CH+-Hafolate by cyanoborohydride reduction using a modifica- 
tion of the procedure described previously (13). lo-CHO-Hlfolate was 
produced by diluting CH+-Hdfolate into anaerobic 50 mM potassium 
phosphate, pH 7.4, containing 5 mM sodium ascorbate and 5 mM 2- 
mercaptoethanol (12). The product formation was complete after 
several hours, and the sample was stored under Nz at -20 “C. 
HPLC Analysis of Reduced Folotes-HPLC analysis of reduced 
folates was based on the methods described by Duch et al. (14) and 
Mullin et al. (15). All buffers were purged with helium before use. 
Procedures were performed under minimal light. E. coli cell paste 
(fresh or thawed from -70 “C) was suspended in 3 volumes of 1% 
sodium ascorbate and 1% 2-mercaptoethanol per g of cell paste. The 
suspension was passed twice through a French pressure cell and then 
heated for 5 min at 95 “C. The mixture was centrifuged at 15,000 rpm 
for 20 min at 4 “C in an SS34 rotor. The supernatant was then 
incubated with the rat plasma y-glutamyl hydrolase preparation for 
3 h at 37 “C in the dark (1 volume of hydrolase added per 4 to 6 
volumes of E. cofi extract). After 3 h, the mixture was again heated 
at 95 ‘C for 5 min and centrifuged at 15,000 rpm for 10 min at 4 “C 
in an SS34 rotor. The supernatant was adjusted to pH 4.5 with 1.75 
M acetic acid, and the centrifugation was repeated. Samples were 
then diluted by adding 1 volume of water per volume of extract and 
quickly processed on columns (1 x 0.625 cm) of Dowex 50X-4, lOO- 
200 mesh (Bio-Rad Laboratories) as described (14). Processing 
through Sep-Pak Plus C-18 cartridges (Waters) was also as described 
(15, 16). The methanol eluate from the Sep-Pak cartridge was evap- 
orated in a Speed Vat, and the remaining material was resuspended 
in 5 mM 2-mercaptoethanol containing 5 mM sodium ascorbate. These 
samples were made anaerobic and stored at -20 “C under Nz over- 
night. 
HPLC was performed on a 10-r reverse phase C-18 column from 
Alltech Associates (Los Altos, CA). Samples were prepared for injec- 
tion by centrifugation through Spin-X columns (Costar) in an Ep- 
pendorf model 5415 microcentrifuge. The HPLC solvent delivery 
system was a Hewlett-Packard 1099 liquid chromatograph. Spectra 
of the HPLC eluate were monitored continuously using a Hewlett- 
Packard 1040A diode array detector. Chromatography conditions 
were similar to those described by Duch et al. (14): the system utilized 
98-100% of a solvent consisting of 5 mM tetrabutylammonium phos- 
phate, 10 mM ammonium dihydrogen phosphate containing 22-25% 
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FIG. 1. Absorption spectrum of DNA photolyase purified 
from SHAlO. Photolyase in 1 ml of 50 mM Tris-HCl, 1 mM EDTA, 
1 mM 2-mercaptoethanol, 2 M KCI, 20% glycerol was incubated with 
10 ~1 of 20 mM potassium ferricyanide for 20 min on ice. Excess 
ferricyanide was removed by chromatography of the mixture on a 
Sephadex G-25 column (PD-10) equilibrated in 50 mM Tris-HCl, 50 
mM NaCl, 1 mM EDTA. 
methanol with a final pH of 6.1-6.2, and O-2% of 100% methanol. 
The flow rate was 0.9-2.0 ml/min. 
RESULTS 
Overproduction of E. coli DNA Photolyase in an LH18- 
derived Strain-We obtained PA414 and LHl8 with the hope 
of overproducing E. coli DNA photolyase in one of these 
strains. The E. coli DNA photolyase (deoxyribodipyrimidine 
photolyase, EC 4.1.99.3) is a monomeric protein with a 
molecular mass of 54,000 daltons which contains as 
tightly bound prosthetic groups FADH* and CH+- 
H,folylpolyglutamate (9,1’7). Although the normal copy num- 
ber of this enzyme is 15-20 molecules per cell, when a plasmid 
containing the photolyase gene, phr, is placed in various E. 
coli hosts and induced, the enzyme can constitute 5-10% of 
the total cellular protein (5). Photolyase purified from such 
an overproducing strain contains approximately 0.3 mol of 
the folate cofactor per mol of protein with some variation 
from preparation to preparation (12). Since the enzyme read- 
ily binds exogenously added 5,10-CH+-H4folate, the less than 
stoichiometric amount of folate in the isolated enzyme ap- 
pears to be due to an insufficiency of intracellular folate to 
meet the demand of enzyme overproduction. By overproduc- 
ing the photolyase in a fol- strain, we hoped to obtain enzyme 
completely free of folate. Although the folate cofactor can be 
Time (mid 
160 I- n 
01 ’ I I 4 \I I 
250 300 350 400 450 SC0 
Wavelength (nm> 
FIG. 2. Top, HPLC profile at 350 nm of the acid-released cofactors 
from photolyase purified from SHAlO. 1 ml of 20 pM photolyase was 
acidified to pH 1 with 4 N HCl, centrifuged for 5 min in an Eppendorf 
microcentrifuge, and applied to a C-18 column equilibrated in 20% 
methanol, pH 2. The sample was chromatographed using a ZO-min 
gradient from 20% methanol to 50% methanol at pH 2 at 1 ml/min. 
Bottom, absorption spectrum of the peak marked by the arrow, 
obtained on-line with a diode-array detector. The material in the 
peak is identified as CH’-Hlfolate. 
removed by chemical treatment (12), we wished to obtain 
enzyme free of folate without the additional chemical treat- 
ment. 
When LH18 was transformed with pMSl310 to give SHAlO 
and photolyase was induced and purified from this strain, the 
isolated enzyme displayed the spectrum shown in Fig. 1. The 
presence of the peak at 384 nm in this enzyme and its relative 
amplitude compared to the radical flavin peak at 580 nm 
indicated that the protein contained CH+-H,folate. The pres- 
ence of this reduced folate was verified by HPLC; Fig. 2 shows 
the HPLC chromatogram of the acid-released cofactors from 
photolyase purified from SHAlO. The spectrum shown in Fig. 
2 was obtained by an on-line scan of the material in the single 
peak indicated by an arrow on the HPLC chromatogram and 
is identical with standard CH+-H*folate. From analysis of 
these results, it is evident that photolyase from this particular 
preparation was approximately 20% saturated with the re- 
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TABLE II 
Extent of overproduction of photolyase in fol- and fol' strains 
Values were obtained by protein assay or by gel scan. 




duced folate cofactor. The photolyase purified from SHAlO 
was indistinguishable from that isolated from MS09 both 
spectrally and by its elution behavior on Blue Sepharose and 
Sephadex G-25. 
Strain UNC414 was constructed from the fol- strain PA414 
in order to determine whether photolyase overproduction in 
this strain also yielded an enzyme preparation partly satu- 
rated with the reduced folate cofactor. Our analysis revealed 
that the photolyase purified from UNC414 was 25% saturated 
with CH’-H,folate (data not shown). 
Previous experiments have indicated that the overproduced 
photolyase is only partially saturated with folate in uiuo in 
wild type MS09; supplementation of the MS09 crude extract 
with CH+-H,folate resulted in isolation of photolyase contain- 
ing virtually a full complement of the folate cofactor after 
purification (12). Therefore, it appears unlikely that the ex- 
tent of overproduction in the fol- mutants would be affected 
by intracellular folate levels. In fact, photolyase purified from 
the fol- mutants is saturated with the folate cofactor to 60- 
80% of the level seen for photolyase purified from the wild 
type strain, and both of the fol- mutants overproduce photo- 
lyase to approximately the same extent as the wild type strain. 
As shown in Table II, the extent of overproduction of photo- 
lyase in SHAlO was 3-4%. Even though the extent of over- 
production for SHAlO is slightly less than that obtained with 
MS09, this lower yield probably reflects the poorer growth of 
this particular fol- strain. The more vigorous PA414-derived 
strain, UNC414, overproduces photolyase as well as the wild 
type strain, MS09 (5.8% for UNC414 compared to 5.5% for 
MS09). It is evident that the amount of the CH+-H,folate 
present in both fol- mutants is considerable. There is no 
evidence that photolyase can produce CH’-H,folate from a 
H,folate precursor; our findings are that it binds only 5,10- 
CH+-H4folate/10-CHO-Hrfolate (12). The results of photo- 
lyase overproduction in both of these fol- strains have led to 
the conclusion that another source for fully reduced folates 
besides the dihydrofolate reductase must exist. 
Analysis of Reduced Folates by HPLC-Since the for strains 
UNC414 and SHAlO were able to maintain enough CH’- 
H,folate to partly saturate the overproduced photolyase, it 
was of interest to determine whether other H4folates were 
also present in these dihydrofolate reductase-deficient strains. 
Most of the analytical procedures for folate analysis that have 
been developed were intended for mammalian cells, but 
seemed adaptable to E. coli cells. The analytical procedure of 
choice involved cleavage of the polyglutamates to monoglu- 
tamates in the crude extracts using rat plasma y-glutamyl 
hydrolase, passage of the treated extracts over Dowex which 
retains the folates, elution of the folates from Dowex, and 
concentration of the folates on a Sep-Pak C-18 cartridge. 
Representative HPLC chromatograms of extracts from 
NM522 and AB1157, the two parent strains of LH18 and 
PA414, are shown in Fig. 3. Each chromatogram represents 
about 2.5 g of E. coli cell paste. In all cases, the presence of 
the individual folates in the extracts was verified by co-elution 
with the corresponding folate standard, as well as by compar- 
ison of the spectrum of the eluting species obtained on line 
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FIG. 3. HPLC profile at 280 nm of folate cofactors from 2.5 
g of NM522 cells (top) and from 2.5 g of AB115’7 cells (bot- 
tom) treated as described in the text. Before HPLC, the extracts 
in 5 mM sodium ascorbate, 5 mM 2-mercaptoethanol were passed 
through Spin-X columns by centrifugation in an Eppendorf micro- 
centrifuge. Chromatography was in 5 mM tetrabutylammonium phos- 
phate, 10 mM ammonium dihydrogen phosphate, 22% methanol, pH 
6.1, at a flow rate of 0.9 ml/min. The numbered peaks are labeled as 
follows: I, lo-CHO-H,folate; ZZ, H,folate; III, 5-CHO-H,folate; ZV, 
Hpfolate; V, folate; and VZ, CHs-H,folate. 
folate compound. The numerals indicate the folates identified 
in each of the extracts. In these extracts, lo-CHO-H,folate, 
H4folate, CHs-H,folate, and traces of folic acid were identified. 
Representative chromatograms of extracts from LH18 and 
PA414 as well as a chromatogram of several folate standard 
compounds are shown in Fig. 4. Each of the chromatograms 
for the fol- extracts represents approximately 4 g of E. coli 
cell paste. The chromatography conditions were slightly dif- 
ferent for the chromatograms in Fig. 4, and all folates exhibit 
shorter retention times relative to the chromatograms in Fig. 
3 as a result. Under these conditions, the H,folate peak, 
indicated by the arrows in Fig. 4, is obscured by UV-absorbing 
material. The chromatography was repeated under conditions 
that better resolved the H,folate peaks in the mutants, and a 
distinct Hdfolate peak was observed for each of the fol- mu- 
tants with a magnitude of about 50% less than that of the 
Hlfolate peak shown in Fig. 3 for the parent strains (data not 
shown). By these methods, we have verified the presence of 
H4folate, CHB-H,folate, folic acid, and lo-CHO-H,folate in 
the fol- strains. 
The relative amounts and the distribution of these folates 
can be seen by a comparison of the different HPLC chromat- 
ograms in Fig. 3 and Fig. 4, keeping in mind that the chro- 
matograms for the fol- strains were obtained using 1.6-fold 
more sample. lo-CHO-H,folate is the major folate species in 
both of the for strains and the parent strains. However, there 
appears to be slightly more of this species in the parent 
strains, since the amounts are approximately equal in the 
chromatograms but more material was injected for the fol- 
strain analysis. The serum y-glutamyl hydrolase controls 
indicated that there was not any folate material in the serum 
preparations (data not shown). Extracts of the strains con- 
taining internal folate standards were analyzed for folate 
content, and the recovery of the internal standards was com- 




FIG. 4. HPLC profile at 280 nm of standard folates (top) 
and folates from 4 g of LHl8 cells (middle) or 4 g of PA414 
cells (bottom). Extracts in 5 mM sodium ascorbate, 5 mM Z-mercap- 
toethanol were centrifuged through Spin-X columns and immediately 
injected. Chromatography was in 98% solvent A and 2% solvent B at 
a flow rate of 1.8 ml/min. Solvent A consisted of 5 mM tetrabutyl- 
ammonium phosphate, 10 mM ammonium dihydrogen phosphate, 
24% methanol, pH 6.1, and solvent B consisted of 100% methanol. 
The labeled peaks are as follows: Z, lo-CHO-H1folate; ZI, Hlfolate; IZZ, 
5CHO-Hlfolate; ZV, H*folate; V, folate; and VZ, CHa-Hlfolate. The 
arrows indicate the position of the H,folate peaks which were ob- 
scured by UV-absorbing material in these chromatograms. 
parable between the strains (data not shown). These recov- 
eries were also comparable to yields of the folate standard 
controls. 
The yields of each standard when carried through the 
procedure with and without added E. eoli crude extract are 
somewhat lower than those reported by Duch et al. (14) and 
vary between 20 and 50% for all species but I&folate and 5- 
CHO-H,folate which are on the order of 10%. The low yields 
of Hzfolate and 5-CHO-H4folate were expected, although the 
yields of the other folates have been reported to be higher 
than ours (14). We attribute our lower yields to the fact that 
the ionic strengths of our extracts were certainly higher due 
to the relative impurity and proportionally greater volume of 
y-glutamyl hydrolase that was used. It was disappointing that 
we could not obtain better yields of Hafolate, since it would 
have been useful to see how much Hpfolate was present in the 
fol- strains relative to the fol’ strains. 
Dihydrofolate Reductase Assays of PA414, LH18, AB11.57, 
and N&&522--Both PA414 and LH18 were constructed by 
deleting the fol gene so that spontaneous reversions could not 
occur (2, 4). The fol gene was in fact replaced with the gene 
coding for kanamycin resistance so that the fol- phenotype 
was easily verifiable. The phenotypes of both mutants have 
been confirmed by enzymatic assays and Southern blot ex- 
periments (2,4). We have also confirmed that crude extracts 
of PA414 and LH18 contain no dihydrofolate reductase activ- 
ity. Assays of crude extracts of PA414 and LH18 and the two 
parent strains AB1157 and NM522 as well as another fol+ 
strain, MJ7, are shown in Table III. The fol- strains show a 
very small and inconsistent rate of change in absorbance at 
340 nm. This rate is similar to the background rate of NADPH 
oxidation in foZ+ strains. If this rate is significant, then the 
observation that it is not eliminated completely in assays of 
PA414 incubated with methotrexate might indicate that it 
represents an “alternative” reductase activity with dihydro- 
folate that might be present in all strains but elevated in 
PA414. In separate assays, extracts of SHAlO and UNC414 
were also shown to contain no dihydrofolate reductase activity 
(data not shown). 
Growth Requirements for PA414 and LHlS-The reports of 
the growth requirements for PA414 and LH18 (2, 4) seemed 
inconsistent. PA414 reportedly required only added thymine 
for growth, but LH18 required all of the folate-dependent end 
products (thymine, adenine, glycine, methionine, and pan- 
tothenic acid) for growth. Both of the strains were constructed 
with mutations in the gene coding for thymidylate synthetase 
since the fol mutations were otherwise lethal. Both mutants 
would be expected to require thymine for growth because of 
the thymidylate synthetase mutation. However, the report 
that LH18 requires all folate end products for growth is 
inconsistent with the presence of the reduced folates in the 
cell that we observed. We have found that both LH18 and 
PA414 demonstrate a requirement for thymine but not for 
the additional folate end products. Both grew on minimal 
plates containing kanamycin and thymine or kanamycin, 
thymine, adenine, glycine, methionine, and pantothenate. 
Neither grew on minimal plates containing only kanamycin. 
This is consistent with the fact that each strain contains 
Rfolates. 
DISCUSSION 
Our results show unambiguously that two E. coli strains 
that are devoid of dihydrofolate reductase activity contain 
significant quantities of reduced folates. The presence of these 
reduced folates was first inferred in LH18; photolyase, an 
enzyme containing a tightly bound reduced folate cofactor, 
was overproduced and purified from SHAlO, a derivative of 
LH18, and shown to contain the reduced folate cofactor. This 
reduced folate cofactor was also isolated from photolyase 
purified from UNC414, a derivative of PA414. This finding, 
that a H*folate was present in sufficient quantity in these fol- 
strains to partly saturate the overproduced photolyase, was 
TABLE III 
Activities of E. coli extracts 
Assays are composite. Values were normalized to 1 mg of protein 
from crude extract added per assay. The concentration of methotrex- 
ate (MTX) was 1 WM. 
Strain Decrease in absorbance at 340 nm 
NM522 0.043 
NM522 + MTX 0.000 
LH18 0.0016 
LH18 + MTX 0.000 
AB1157 0.036 
AB1157 + MTX 0.000 
PA414 0.0015 
PA414 + MTX 0.002 
MJ7 0.047 
MJ7 + MTX 0.000 
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unexpected. The extent of saturation of the enzyme with the 
CH+-Hlfolate in both cases was 60-80% of that of enzyme 
obtained from the fol’ strain. The dihydrofolate reductase 
Iesion in LH18 and PA414 had abolished the activity pre- 
sumed to be responsible for the generation of all cellular 
H4folates in E. coli. That the dihydrofolate reductase activity 
was in fact absent was verified by assays of crude extracts of 
LH18 and PA414. Reversion to the wild type is impossible 
for these fol- mutants since the dihydrofolate reductase mu- 
tation was created by deleting the fol gene. 
Quantitative folate analysis of both mutants revealed that 
in fact several different reduced folates were present; lo- 
CHO-H,folate, CH3-Hbfolate, Rfolate, and folic acid. The 
presence of lo-CHO-H,folate as the major species in chro- 
matograms of all of the strains is consistent with its essential 
role in the cell; it is responsible for the generation of N’“- 
CHO-methionine which is required as the initial amino acid 
for protein synthesis. IO-CHO-H,folate also serves a critical 
role as a cofactor in de nouo purine biosynthesis. There is a 
small amount of H4folate in the fol- strains, and about twice 
that in the parent strains. Most of the CH*-Hhfolate present 
in the cell is converted to Hlfolate during the isolation pro- 
cedure (14). Since the major cellular reaction requiring CH,- 
Hlfolate is the reaction catalyzed by thymidylate synthetase, 
it is not surprising that there is more Hlfolate in the parent 
strains containing this enzyme than in the fol-thyA- mutants. 
There appears to actually be more of the CH3-Hbfolate species 
in the fol- strains than in the parent strains. The fact that 
the major folate species in the cell was the lo-CHO-H4folate 
explains the finding that photolyase from SHAlO and 
UNC414 was saturated with 5,10-CH+-H,folate to almost the 
same extent as photolyase from the fol+ strain, MS09. 
The presence of reduced folates in E. coli lacking dihydro- 
folate reductase explains the previously reported failure of the 
PA414 mutant to display folate end product auxotrophy (4). 
Depletion of the folate pool by thymidylate synthetase in the 
absence of dihydrofolate reductase seems to be the most likely 
explanation for the deleterious effect on cells of fol-thyA+. 
Our findings imply that there must be another enzyme or 
metabolic pathway responsible for the generation of Hlfolates 
in E. coli fol- mutants. The recently identified dihydropteri- 
dine reductase of E. coli (18, 19) appears to be a likely 
candidate for this activity. Dihydropteridine (or dihydrop- 
terin) reductases are found primarily in mammalian cells 
containing the aromatic amino acid hydroxylases. These ar- 
omatic amino acid hydroxylases require H4biopterin as a 
cofactor; during the course of the reaction, quinonoid-7,8- 
HPbiopterin is generated and requires reduction to the 5,6,7,8- 
H4biopterin cofactor (20). This reduction step is catalyzed by 
the dihydropteridine reductase in a reaction requiring 
NADPH. 
E. coli does not contain any known aromatic amino acid 
hydroxylases, yet the presence of the dihydropteridine reduc- 
tase has been recently documented. The function of this 
enzyme in E. coli is unknown. Analysis of the pterin compo- 
sition of E. coli by HPLC reveals mainly monapterin with 
trace amounts of pterin and biopterin (18). These three pter- 
ins have no known function in E. coli. Also present in E. coli 
is molybdopterin (6); this pterin forms the molybdenum co- 
factor for enzymes such as nitrate reductase and dimethyl 
sulfoxide reductase. The cofactor itself is tightly bound to 
enzymes, but during biosynthesis the pterin may require ring 
reduction by an enzyme such as dihydropteridine reductase. 
Characterization of the E. coli dihydropteridine reductase 
indicates that it is a monomeric enzyme of molecular mass 
27,000 daltons, contains a flavin prosthetic group, accepts 
NADH and NADPH as a reducing substrate (although NADH 
is preferred in uitro with the quinonoid-H2pterin substrates), 
and can use a variety of quinonoid-Hzpterin substrates (18, 
19). A recent report states that it has activity with H*folate 
as well, at a rate 5% of that seen with the quinonoid-H2pterin 
substrates (19). 
The activity observed in vitro with Hzfolate is not unprec- 
edented. Rat liver dihydropteridine reductase acts efficiently 
on quinonoid-H*folates and, less efficiently, on H*folates (20). 
The rat liver enzyme is also competitively inhibited by several 
folate analogues including 2,4-diaminopteroate and aminop- 
terin. Other mammalian dihydropteridine reductases are in- 
hibited by methotrexate (20), as is the E. coli enzyme (18, 19). 
In addition, dihydropteridine reductases have been identified 
in mammalian tissues which do not contain amino acid hy- 
droxylases. One explanation proposed to explain this finding 
is that the nonenzymatic oxidation of H,folate produces a 
quinonoid-H*folate species which might be regenerated to the 
H4folate by dihydropteridine reductase (20). In this way, 
Hlfolate pools might be protected under conditions where 
dihydrofolate reductase activity is minimal. This same sce- 
nario is applicable to the fol- mutants. It is possible that in 
cells lacking dihydrofolate reductase this enzyme can catalyze 
the reduction of 7,8-H*folate to H4folate at a slow but signif- 
icant rate. 
If the dihydropteridine reductase of E. coli is responsible 
for the generation of the cellular reduced folate pool, then the 
lethal nature of the fol-thyA+ combination is explained. In 
the absence of thymidylate synthetase, the dihydropteridine 
reductase catalyzes a slow but steady reduction of 7,8-H*folate 
to Hlfolate. In the presence of thymidylate synthetase, this 
rate is unable to keep up with the rapid production of Hpfolate 
by thymidylate synthetase. Under these conditions, the cells 
cannot maintain a reduced folate pool necessary to carry out 
the other folate-requiring reactions essential for growth, and 
the cells die. It would be interesting to see if dihydropteridine 
reductase levels are elevated in the E. coli fol- mutants. 
Reduction of Hnfolate by either a primary or auxiliary 
function of dihydropteridine reductase is only one scenario 
for these fol- mutants, although it appears to be the most 
likely. Another possibility is that folates may be synthesized 
as quinonoid species and that the terminal step in folate 
biosynthesis in E. coli is not catalyzed by dihydrofolate reduc- 
tase but rather by the dihydropteridine reductase. In this 
scheme, one of the postulated HZ-precursors shown in Scheme 
1 might undergo a rearrangement to a quinonoid precursor. 
Dihydrofolate reductase would function in this scheme by 
reducing the 7,8-Hzfolate produced in the thymidylate syn- 
thetase reaction. The fact that the folate levels in LH18 and 
PA414 are not quite as high as the levels in the parent strains 
makes this scenario less likely. However, in the absence of 
thymidylate synthetase, overall folate production may be de- 
creased since one major folate-requiring pathway is inopera- 
tive. It is possible that another as yet uncharacterized enzyme 
exists in E. coli with the primary or secondary function of 
reducing H*folate. Finally, it is also possible that another 
pathway for folate biosynthesis exists in E. coli that does not 
derive the folate ring from GTP; this, however, is extremely 
unlikely. 
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